← Evidence map

ArticleGlobal cardiology science & practice2021

HbA1c and FIB-4 as serologic markers for the risk of progression of stage A heart failure.

William Grigg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36185157